Facile Synthesis and Anticancer Evaluation of Novel 1-(Thiazol-2-yl)-3-(thiazol-5-yl)-5-(thiophen-2-yl) Pyrazolines
Crossref DOI link: https://doi.org/10.1134/S1070363222060226
Published Online: 2022-07-07
Published Print: 2022-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bondock, Samir
Albormani, Omeer
Fouda, Ahmed M.
Text and Data Mining valid from 2022-06-01
Version of Record valid from 2022-06-01
Article History
Received: 9 January 2022
Revised: 17 January 2022
Accepted: 19 January 2022
First Online: 7 July 2022
CONFLICT OF INTEREST
: No conflict of interest was declared by the authors.